Literature DB >> 1649703

TrkB mediates BDNF/NT-3-dependent survival and proliferation in fibroblasts lacking the low affinity NGF receptor.

D J Glass1, S H Nye, P Hantzopoulos, M J Macchi, S P Squinto, M Goldfarb, G D Yancopoulos.   

Abstract

The neurotrophins (nerve growth factor [NGF], brain-derived neurotrophic factor [BDNF], neurotrophin-3 [NT-3], and neurotrophin-4 [NT-4] ) have been defined by their ability to support neuronal survival. These factors utilize the Trk family of receptor tyrosine kinases, perhaps in conjunction with a second component known as the low affinity NGF receptor (LNGFR). Here we demonstrate that TrkB mediates survival and proliferation in response to both BDNF and NT-3 when expressed in a particular strain of NIH 3T3 fibroblasts, with BDNF the more potent ligand. Furthermore, the BDNF dose dependency displayed by these TrkB-expressing fibroblasts is similar to that required to support the survival of primary neurons. The LNGFR is not expressed in our fibroblast system, implying that this receptor is not essential for responses to physiological concentrations of the neurotrophins. We discuss our findings in the context of neurotrophin signaling pathways and mechanisms of neuronal cell death.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1649703     DOI: 10.1016/0092-8674(91)90629-d

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  37 in total

1.  Carboxyl-directed pegylation of brain-derived neurotrophic factor markedly reduces systemic clearance with minimal loss of biologic activity.

Authors:  T Sakane; W M Pardridge
Journal:  Pharm Res       Date:  1997-08       Impact factor: 4.200

2.  Constitutive expression of the low-affinity neurotrophin receptor and changes during axotomy-induced death of sensory neurones in the neonatal rat dorsal root ganglion.

Authors:  Simon S Murray; Surindar S Cheema
Journal:  J Anat       Date:  2003-02       Impact factor: 2.610

3.  HAP1 Is Required for Endocytosis and Signalling of BDNF and Its Receptors in Neurons.

Authors:  Yoon Lim; Linda Lin-Yan Wu; Si Chen; Ying Sun; Swarna Lekha Vijayaraj; Miao Yang; Larisa Bobrovskaya; Damien Keating; Xiao-Jiang Li; Xin-Fu Zhou
Journal:  Mol Neurobiol       Date:  2017-01-12       Impact factor: 5.590

4.  Combined use of carboxyl-directed protein pegylation and vector-mediated blood-brain barrier drug delivery system optimizes brain uptake of brain-derived neurotrophic factor following intravenous administration.

Authors:  W M Pardridge; D Wu; T Sakane
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

5.  Targeted taste cell-specific overexpression of brain-derived neurotrophic factor in adult taste buds elevates phosphorylated TrkB protein levels in taste cells, increases taste bud size, and promotes gustatory innervation.

Authors:  Irina V Nosrat; Robert F Margolskee; Christopher A Nosrat
Journal:  J Biol Chem       Date:  2012-03-22       Impact factor: 5.157

6.  Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma.

Authors:  R A Segal; L C Goumnerova; Y K Kwon; C D Stiles; S L Pomeroy
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

7.  Neurotrophin 3 is a mitogen for cultured neural crest cells.

Authors:  C Kalcheim; C Carmeli; A Rosenthal
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

8.  High-affinity neurotrophin receptors and ligands promote leukemogenesis.

Authors:  Zhixiong Li; Gernot Beutel; Mathias Rhein; Johann Meyer; Christian Koenecke; Thomas Neumann; Min Yang; Jürgen Krauter; Nils von Neuhoff; Michael Heuser; Helmut Diedrich; Gudrun Göhring; Ludwig Wilkens; Brigitte Schlegelberger; Arnold Ganser; Christopher Baum
Journal:  Blood       Date:  2008-12-04       Impact factor: 22.113

9.  Increased levels of trkB mRNA and trkB protein-like immunoreactivity in the injured rat and cat spinal cord.

Authors:  J Frisén; V M Verge; S Cullheim; H Persson; K Fried; D S Middlemas; T Hunter; T Hökfelt; M Risling
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

10.  Nerve growth factor suppresses the transforming phenotype of human prolactinomas.

Authors:  C Missale; F Boroni; M Losa; M Giovanelli; A Zanellato; R Dal Toso; A Balsari; P Spano
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.